Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression

Vinata B. Lokeshwar, Bal L. Lokeshwar, Henri T. Pham, Norman L Block

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

Components of extracellular matrix and the matrix-degrading enzymes are some of the key regulators of tumor metastasis and angiogenesis. Hyaluronic acid (HA), a matrix glycosaminoglycan, is known to promote tumor cell adhesion and migration, and its small fragments are angiogenic. We have compared levels of hyaluronidase, an enzyme that degrades HA, in normal adult prostate (NAP), benign prostate hyperplasia (BPH) and prostate cancer (CaP) tissues and in conditioned media from epithelial explant cultures, using a sensitive substrate(HA)-gel assay and an ELISA-like assay. The results show a significant elevation (3-10-fold) of this enzyme in tumor tissues compared to that in NAP and BPH tissues. Furthermore, the hyaluronidase levels in tissues correlate well with the tumor grade. For example, the concentrations in a locally extended CaP lesion (191 ± 7.9 milliunits/mg protein) are the highest, followed by high-grade tumors (36.6 ± 2.9 milliunits/mg protein), and low-grade tumors (9.4 ± 1.4 milliunits/mg protein), respectively. Among the primary epithelial explant cultures, CaP cultures secrete at least 10- fold higher levels of hyaluronidase than those secreted by NAP and BPH cultures. Furthermore, among the established prostate cancer cell lines, DU145, an androgen-unresponsive metastatic line, secretes 4-fold more hyaluronidase than LNCaP, an androgen-responsive and relatively well- differentiated cell line. We also show that prostatic hyaluronidase has an apparent M(r) ≃55,000, a pH optimum of 4.6, and is distinct from other well- characterized hyaluronidases.

Original languageEnglish
Pages (from-to)651-657
Number of pages7
JournalCancer Research
Volume56
Issue number3
StatePublished - Feb 1 1996

Fingerprint

Hyaluronoglucosaminidase
Prostate
Prostatic Neoplasms
Enzymes
Hyaluronic Acid
Hyperplasia
Neoplasms
Androgens
Cell Line
Proteins
Conditioned Culture Medium
Glycosaminoglycans
Cell Adhesion
Cell Movement
Extracellular Matrix
Gels
Enzyme-Linked Immunosorbent Assay
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lokeshwar, V. B., Lokeshwar, B. L., Pham, H. T., & Block, N. L. (1996). Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Research, 56(3), 651-657.

Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. / Lokeshwar, Vinata B.; Lokeshwar, Bal L.; Pham, Henri T.; Block, Norman L.

In: Cancer Research, Vol. 56, No. 3, 01.02.1996, p. 651-657.

Research output: Contribution to journalArticle

Lokeshwar, VB, Lokeshwar, BL, Pham, HT & Block, NL 1996, 'Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression', Cancer Research, vol. 56, no. 3, pp. 651-657.
Lokeshwar, Vinata B. ; Lokeshwar, Bal L. ; Pham, Henri T. ; Block, Norman L. / Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. In: Cancer Research. 1996 ; Vol. 56, No. 3. pp. 651-657.
@article{528f97c6a3f248bab22df499b73bcd5d,
title = "Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression",
abstract = "Components of extracellular matrix and the matrix-degrading enzymes are some of the key regulators of tumor metastasis and angiogenesis. Hyaluronic acid (HA), a matrix glycosaminoglycan, is known to promote tumor cell adhesion and migration, and its small fragments are angiogenic. We have compared levels of hyaluronidase, an enzyme that degrades HA, in normal adult prostate (NAP), benign prostate hyperplasia (BPH) and prostate cancer (CaP) tissues and in conditioned media from epithelial explant cultures, using a sensitive substrate(HA)-gel assay and an ELISA-like assay. The results show a significant elevation (3-10-fold) of this enzyme in tumor tissues compared to that in NAP and BPH tissues. Furthermore, the hyaluronidase levels in tissues correlate well with the tumor grade. For example, the concentrations in a locally extended CaP lesion (191 ± 7.9 milliunits/mg protein) are the highest, followed by high-grade tumors (36.6 ± 2.9 milliunits/mg protein), and low-grade tumors (9.4 ± 1.4 milliunits/mg protein), respectively. Among the primary epithelial explant cultures, CaP cultures secrete at least 10- fold higher levels of hyaluronidase than those secreted by NAP and BPH cultures. Furthermore, among the established prostate cancer cell lines, DU145, an androgen-unresponsive metastatic line, secretes 4-fold more hyaluronidase than LNCaP, an androgen-responsive and relatively well- differentiated cell line. We also show that prostatic hyaluronidase has an apparent M(r) ≃55,000, a pH optimum of 4.6, and is distinct from other well- characterized hyaluronidases.",
author = "Lokeshwar, {Vinata B.} and Lokeshwar, {Bal L.} and Pham, {Henri T.} and Block, {Norman L}",
year = "1996",
month = "2",
day = "1",
language = "English",
volume = "56",
pages = "651--657",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression

AU - Lokeshwar, Vinata B.

AU - Lokeshwar, Bal L.

AU - Pham, Henri T.

AU - Block, Norman L

PY - 1996/2/1

Y1 - 1996/2/1

N2 - Components of extracellular matrix and the matrix-degrading enzymes are some of the key regulators of tumor metastasis and angiogenesis. Hyaluronic acid (HA), a matrix glycosaminoglycan, is known to promote tumor cell adhesion and migration, and its small fragments are angiogenic. We have compared levels of hyaluronidase, an enzyme that degrades HA, in normal adult prostate (NAP), benign prostate hyperplasia (BPH) and prostate cancer (CaP) tissues and in conditioned media from epithelial explant cultures, using a sensitive substrate(HA)-gel assay and an ELISA-like assay. The results show a significant elevation (3-10-fold) of this enzyme in tumor tissues compared to that in NAP and BPH tissues. Furthermore, the hyaluronidase levels in tissues correlate well with the tumor grade. For example, the concentrations in a locally extended CaP lesion (191 ± 7.9 milliunits/mg protein) are the highest, followed by high-grade tumors (36.6 ± 2.9 milliunits/mg protein), and low-grade tumors (9.4 ± 1.4 milliunits/mg protein), respectively. Among the primary epithelial explant cultures, CaP cultures secrete at least 10- fold higher levels of hyaluronidase than those secreted by NAP and BPH cultures. Furthermore, among the established prostate cancer cell lines, DU145, an androgen-unresponsive metastatic line, secretes 4-fold more hyaluronidase than LNCaP, an androgen-responsive and relatively well- differentiated cell line. We also show that prostatic hyaluronidase has an apparent M(r) ≃55,000, a pH optimum of 4.6, and is distinct from other well- characterized hyaluronidases.

AB - Components of extracellular matrix and the matrix-degrading enzymes are some of the key regulators of tumor metastasis and angiogenesis. Hyaluronic acid (HA), a matrix glycosaminoglycan, is known to promote tumor cell adhesion and migration, and its small fragments are angiogenic. We have compared levels of hyaluronidase, an enzyme that degrades HA, in normal adult prostate (NAP), benign prostate hyperplasia (BPH) and prostate cancer (CaP) tissues and in conditioned media from epithelial explant cultures, using a sensitive substrate(HA)-gel assay and an ELISA-like assay. The results show a significant elevation (3-10-fold) of this enzyme in tumor tissues compared to that in NAP and BPH tissues. Furthermore, the hyaluronidase levels in tissues correlate well with the tumor grade. For example, the concentrations in a locally extended CaP lesion (191 ± 7.9 milliunits/mg protein) are the highest, followed by high-grade tumors (36.6 ± 2.9 milliunits/mg protein), and low-grade tumors (9.4 ± 1.4 milliunits/mg protein), respectively. Among the primary epithelial explant cultures, CaP cultures secrete at least 10- fold higher levels of hyaluronidase than those secreted by NAP and BPH cultures. Furthermore, among the established prostate cancer cell lines, DU145, an androgen-unresponsive metastatic line, secretes 4-fold more hyaluronidase than LNCaP, an androgen-responsive and relatively well- differentiated cell line. We also show that prostatic hyaluronidase has an apparent M(r) ≃55,000, a pH optimum of 4.6, and is distinct from other well- characterized hyaluronidases.

UR - http://www.scopus.com/inward/record.url?scp=0030059196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030059196&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 651

EP - 657

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 3

ER -